BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29512398)

  • 1. Analysis of factors associated with development of Bacille Calmette-Guérin inoculation site change in patients with Kawasaki disease.
    Araki T; Kodera A; Kitada K; Fujiwara M; Muraoka M; Abe Y; Ikeda M; Tsukahara H
    J Int Med Res; 2018 Apr; 46(4):1640-1648. PubMed ID: 29512398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site.
    Uehara R; Igarashi H; Yashiro M; Nakamura Y; Yanagawa H
    Pediatr Infect Dis J; 2010 May; 29(5):430-3. PubMed ID: 20032807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease.
    Lai CC; Lee PC; Wang CC; Hwang BT; Meng CC; Tsai MC
    Pediatr Neonatol; 2013 Feb; 54(1):43-8. PubMed ID: 23445742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Kawasaki disease before and after universal Bacille Calmette-Guérin vaccination program was discontinued.
    Pasma H; Honkila M; Pokka T; Renko M; Salo E; Tapiainen T
    Acta Paediatr; 2020 Apr; 109(4):842-846. PubMed ID: 31520428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of the BCG Scar in the Acute Phase of Kawasaki Disease in Mexican Children.
    Garrido-García LM; Castillo-Moguel A; Vázquez-Rivera M; Cravioto P; Fernando G
    Pediatr Infect Dis J; 2017 Oct; 36(10):e237-e241. PubMed ID: 28498302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two infants with tuberculid associated with Kawasaki disease.
    Yamada H; Ohta H; Hasegawa S; Azuma Y; Hasegawa M; Kadoya R; Ohbuchi N; Ohnishi Y; Okada S; Hoshide M; Ohga S
    Hum Vaccin Immunother; 2016 Nov; 12(11):2772-2776. PubMed ID: 27435523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki Disease.
    Kakisaka Y; Ohara T; Katayama S; Suzuki T; Sasai S; Hino-Fukuyo N; Kure S
    Tohoku J Exp Med; 2012 Dec; 228(4):351-3. PubMed ID: 23138414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG and Kawasaki disease in Mexico and Japan.
    Gamez-Gonzalez LB; Hamada H; Llamas-Guillen BA; Ruiz-Fernandez M; Yamazaki-Nakashimada M
    Hum Vaccin Immunother; 2017 May; 13(5):1091-1093. PubMed ID: 28281896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIAGNOSTIC VALUE OF THE REACTION AT THE BACILLUS CALMETTE-GUÉRIN VACCINATION SITE IN KAWASAKI DISEASE.
    Diniz LMO; Castanheira RG; Giampietro YG; Silva MS; Nogueira FD; Pessoa PD; Santos TMDS; Coutinho GS; Romanelli RMC
    Rev Paul Pediatr; 2021; 39():e2019338. PubMed ID: 32876305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bull's eye dermatoscopy pattern at bacillus Calmette-Guérin inoculation site correlates with systemic involvements in patients with Kawasaki disease.
    Tseng HC; Ho JC; Guo MM; Lo MH; Hsieh KS; Tsai WC; Kuo HC; Lee CH
    J Dermatol; 2016 Sep; 43(9):1044-50. PubMed ID: 26935002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of Kawasaki disease after simultaneous immunization.
    Matsubara D; Minami T; Seki M; Tamura D; Yamagata T
    Pediatr Int; 2019 Nov; 61(11):1171-1173. PubMed ID: 31709668
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.
    Loh ACE; Kua PHJ; Tan ZL
    Singapore Med J; 2019 Feb; 60(2):89-93. PubMed ID: 30009317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulceration at Bacillus Calmette-Guérin Inoculation Site in a Patient with Kawasaki Disease.
    Uda K; Hataya H
    J Pediatr; 2015 Nov; 167(5):1167-7.e1. PubMed ID: 26342720
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease.
    Takikawa H; Ae R; Matsubara Y; Matsubara D; Makino N; Kosami K; Kuwabara M; Sasahara T; Nakamura Y
    Arch Dis Child; 2021 Jul; 106(7):669-673. PubMed ID: 33303488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles infection causing Bacillus Calmette-Guérin reactivation: a case report.
    Muthuvelu S; Lim KS; Huang LY; Chin ST; Mohan A
    BMC Pediatr; 2019 Jul; 19(1):251. PubMed ID: 31340782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisystem inflammatory syndrome in children associated with Bacille Calmette-Guérin scar: a case presentation.
    Kizildag H; Hannavi KJ; Gur R; Oztarhan K
    BMC Pediatr; 2023 Mar; 23(1):92. PubMed ID: 36859277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guérin and purified protein derivative inoculation sites.
    Hsu YH; Wang YH; Hsu WY; Lee YP
    Pediatr Infect Dis J; 1987 Jun; 6(6):576-8. PubMed ID: 3615073
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.
    Novais C; Fortunato F; Bicho A; Preto L
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guérin inoculation site.
    Seo JH; Yu JJ; Ko HK; Choi HS; Kim YH; Ko JK
    Korean Circ J; 2012 Dec; 42(12):823-9. PubMed ID: 23323120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study.
    Mancuso JD; Mody RM; Olsen CH; Harrison LH; Santosham M; Aronson NE
    Chest; 2017 Aug; 152(2):282-294. PubMed ID: 28087302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.